Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.46 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1712503 | 0.90 | KMT2A (0.46) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL146099 | 0.78 | CES1 (0.43) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL79975 | 0.77 | KMT2A (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL1898420 | 0.77 | KMT2A (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL6418982 | 0.77 | KMT2A (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL5189613 | 0.74 | KMT2A (0.55) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL144974 | 0.74 | CES1 (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL8745554 | 0.72 | TDP1 (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL302163 | 0.72 | ALDH1A1 (0.43) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL5582134 | 0.72 | TDP1 (0.46) | CES1CES2TSHRALDH1A1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2177522-B1 | NOVEL CARBAPENEM DERIVATIVES | XUANZHU PHARMA CO LTD (CN) | 2013-09-04 | — | — | EP | claimed |
| US-5837873-A | PROTECTED OXYDIAMINES | ABBOTT LABORATORIES (US) | 1998-11-17 | — | — | US | claimed |
| EP-0414533-A1 | Use of iodopropargyl esters of alpha-amino acid derivatives as antimicrobial agents | ROHM AND HAAS COMPANY (US) | 1991-02-27 | — | — | EP | claimed |
| US-10174132-B2 | Heparan sulfate synthesis | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2019-01-08 | — | — | US | disclosed |
| US-9975910-B2 | Hetero-fused cyclic compound | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20160168176-A1 | HETERO-FUSED CYCLIC COMPOUND | Eisai R&D Management Co., Lt.d (JP) | 2016-06-16 | — | — | US | disclosed |
| EP-3026054-A1 | HETERO-CONDENSED RING COMPOUND | Eisai R&D Management Co., Ltd. (JP) | 2016-06-01 | — | — | EP | disclosed |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2016-03-03 | — | — | US | disclosed |
| CN-102603746-B | Carbapenem derivative | KBP BIOSCIENCES CO LTD | 2015-07-15 | — | — | CN | disclosed |
| CN-102977123-B | Cephalosporins compound and pharmaceutically acceptable salt thereof | DENG SHIBI | 2015-04-29 | — | — | CN | disclosed |
| EP-2177522-B1 | NOVEL CARBAPENEM DERIVATIVES | XUANZHU PHARMA CO LTD (CN) | 2013-09-04 | — | — | EP | disclosed |
| EP-2177522-A1 | NOVEL CARBAPENEM DERIVATIVES | KBP Biosciences Co., Ltd. (CN) | 2010-04-21 | — | — | EP | disclosed |
| WO-2009049837-A1 | PROCESS FOR PREPARING 8-HYDRAZINO-8-ARYLOCTANOYL DERIVATIVES AND THEIR USE | REUTER CHEMISCHER APPARATEBAU KG (DE) | 2009-04-23 | — | — | WO | disclosed |
| EP-2039697-A1 | FLUOROBORON COMPOUND, AMINOMETHYLATING AGENT FOR AROMATIC RING COMPRISING THE COMPOUND, AND PROCESS FOR PRODUCTION OF COMPOUND HAVING AMINOMETHYL-AROMATIC RING USING THE AMINOMETHYLATING AGENT | Eisai R&D Management Co., Ltd. (JP) | 2009-03-25 | — | — | EP | disclosed |
| US-20080015351-A1 | Fluoroboron compound, aminomethylating agent for aromatic ring made of the same, and production method of compound containing aminomethyl aromatic ring using aminomethylating agent | EISAI R&D MANAGEMENT CO., LTD. | 2008-01-17 | — | — | US | disclosed |
| EP-1163256-A1 | HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE | Hollis-Eden Pharmaceuticals Inc. (US) | 2001-12-19 | — | — | EP | disclosed |
| WO-2000056757-A1 | IMMUNOMODULATORY STEROIDS, IN PARTICULAR THE HEMIHYDRATE OF 16.ALPHA.-BROMOEPIANDROSTERONE | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2000-09-28 | — | — | WO | disclosed |
| US-5837873-A | PROTECTED OXYDIAMINES | ABBOTT LABORATORIES (US) | 1998-11-17 | — | — | US | disclosed |
| US-5252745-A | Preparation and use of iodopropargyl esters of α-amino acid derivatives as antimicrobial agents | ROHM AND HAAS COMPANY (US) | 1993-10-12 | — | — | US | disclosed |
| EP-0414533-A1 | Use of iodopropargyl esters of alpha-amino acid derivatives as antimicrobial agents | ROHM AND HAAS COMPANY (US) | 1991-02-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10174132-B2 | Heparan sulfate synthesis | HPSE, STT3B, DDOST | CES1 928/4885CES2 949/4885TSHR 3144/4885 |
| US-20080015351-A1 | Fluoroboron compound, aminomethylating agent for aromatic ring made of the same, and production method of compound containing aminomethyl aromatic ring using aminomethylating agent | PRMT6, MLLT3, PRMT3 | CES1 4835/4885CES2 4837/4885TSHR 1465/4885 |
| US-20160168176-A1 | HETERO-FUSED CYCLIC COMPOUND | NR3C2, NR1H4, NR1I3 | CES1 2047/4885CES2 1795/4885TSHR 1103/4885 |
| US-20160060365-A1 | HEPARAN SULFATE SYNTHESIS | HPSE, STT3B, DDOST | CES1 928/4885CES2 949/4885TSHR 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.